Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. (SHE:300937)
23.80
-0.03 (-0.13%)
At close: Oct 9, 2026
SHE:300937 Revenue
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical had revenue of 1.07B CNY in the quarter ending June 30, 2026, with 4.00% growth. This brings the company's revenue in the last twelve months to 4.47B, up 3.20% year-over-year. In the year 2025, Sichuan Hezong Medicine Easy-to-buy Pharmaceutical had annual revenue of 4.45B with 1.35% growth. That makes Sichuan Hezong Medicine Easy-to-buy Pharmaceutical the 9,596th largest company in the world by revenue and 1,523rd in China.
Revenue (ttm)
4.47B
Revenue Growth
+3.20%
P/S Ratio
0.51
Revenue / Employee
n/a
Employees
1,045
Market Cap
2.28B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.45B | 59.44M | 1.35% |
| Dec 31, 2024 | 4.39B | -35.85M | -0.81% |
| Dec 31, 2023 | 4.43B | 461.21M | 11.62% |
| Jan 1, 2023 | 3.97B | 568.62M | 16.72% |
| Jan 1, 2022 | 3.40B | 610.45M | 21.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| DaShenLin Pharmaceutical Group | 27.97B |
| Yifeng Pharmacy Chain | 24.84B |
| LBX Pharmacy Chain Joint Stock Company | 22.46B |
| Luyan Pharma | 21.43B |
| Cachet Pharmaceutical | 18.10B |
| Yixintang Pharmaceutical Group | 16.89B |
| ShuYu Civilian Pharmacy Corp. | 10.76B |
| Jianzhijia Pharmaceutical Chain Group | 8.65B |